CSS LLC’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

CSS LLC’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-19,000	Closed	-$108K	–	772
2015 Q4	$108K	Sell	19,000 -40,000	-68%	-$244K	0.01%	624
2015 Q3	$313K	Sell	59,000 -1,000	-2%	-$7.74K	0.02%	478
2015 Q2	$498K	Buy	60,000 +20,000	+50%	+$96.9K	0.02%	446
2015 Q1	$185K	Buy	+40,000	New	+$130K	0.01%	622

Other funds holding SGYP

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CSS LLC's SGYP Position: Q3 2016 in Review

CSS LLC sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2016, closing a stake of 12,852 shares — an estimated $49K sold.

CSS LLC first reported a position in SGYP in Q1 2016 and held it in 2 quarters. The position peaked at $418K in Q1 2016. 149 funds tracked by Wall St. Rank hold SGYP as of Q3 2016.

CSS LLC reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2016 after selling out during the quarter.
CSS LLC sold 12,852 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2016, an estimated $49K.
CSS LLC first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q1 2016 and held it in 2 quarters.
CSS LLC's Synergy Pharmaceuticals, Inc Common Stock position peaked at $418K in Q1 2016.
149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2016.

Based on CSS LLC's 13F filing for Q3 2016, filed 14 Nov 2016.